Rapport Therapeutics, Inc. Common Stock (RAPP) NASDAQ

25.78

+0.0112(+0.04%)

Updated at October 16 11:42AM

Currency In NaN

Valuation

Market Cap3.68B
Enterprise Value3.62B
P/E Ratio-103.47
PEG Ratio0.63
Price/Sales Ratio1,306.82
Price/Book Ratio34.68
Enterprise/Revenue1,246.81
Enterprise/EBITDA-8.86

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-122.66
Operating Margin-141.34

Management Effectiveness

Return On Assets-0.31
Return On Equity-0.3

Income Statement

Revenue0
Revenue/Share0
Gross Profit-839,000
EBITDA-77.47M
Net Income-78.31M
Diluted EPS-0.38

Balance Sheet

Total Cash260.45M
Total Cash/Share0.73
Total Debt11.86M
Total Debt/Equity0.05
Current Ratio22.75
Book Value Per Share0.74

Price History

52-Week Change-11.8
52-Week High42.27
52-Week Low6.43
Moving Average 50 Days21.36
Moving Average 200 Days14.62

Statistics

Average Volume742,593
Shares Outstanding36.5M
% Held by Institutions10.16

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A